These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22287994)

  • 1. Associating Drugs, Targets and Clinical Outcomes into an Integrated Network Affords a New Platform for Computer-Aided Drug Repurposing.
    Oprea TI; Nielsen SK; Ursu O; Yang JJ; Taboureau O; Mathias SL; Kouskoumvekaki L; Sklar LA; Bologa CG
    Mol Inform; 2011 Mar; 30(2-3):100-111. PubMed ID: 22287994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Drug Repurposing: Current Trends.
    Karaman B; Sippl W
    Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. InContext: curation of medical context for drug indications.
    Moodley K; Rieswijk L; Oprea TI; Dumontier M
    J Biomed Semantics; 2021 Feb; 12(1):2. PubMed ID: 33579375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical connectivity map for drug repurposing: using laboratory results to bridge drugs and diseases.
    Wen Q; Liu R; Zhang P
    BMC Med Inform Decis Mak; 2021 Sep; 21(Suppl 8):263. PubMed ID: 34560862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining.
    Liu TP; Hsieh YY; Chou CJ; Yang PM
    R Soc Open Sci; 2018 Nov; 5(11):181321. PubMed ID: 30564416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database.
    Barneh F; Jafari M; Mirzaie M
    Brief Bioinform; 2016 Nov; 17(6):1070-1080. PubMed ID: 26490381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy.
    Sivapalarajah S; Krishnakumar M; Bickerstaffe H; Chan Y; Clarkson J; Hampden-Martin A; Mirza A; Tanti M; Marson A; Pirmohamed M; Mirza N
    Epilepsia; 2018 Feb; 59(2):492-501. PubMed ID: 29341109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.
    Chartier M; Morency LP; Zylber MI; Najmanovich RJ
    BMC Pharmacol Toxicol; 2017 Apr; 18(1):18. PubMed ID: 28449705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic analysis of FDA-approved anticancer drugs.
    Sun J; Wei Q; Zhou Y; Wang J; Liu Q; Xu H
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):87. PubMed ID: 28984210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repurposing: far beyond new targets for old drugs.
    Oprea TI; Mestres J
    AAPS J; 2012 Dec; 14(4):759-63. PubMed ID: 22826034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Web-based Tools for Drug Repurposing: Successful Examples of Collaborative Research.
    Vanhaelen Q
    Curr Med Chem; 2021; 28(1):181-195. PubMed ID: 32003659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adera2.0: A Drug Repurposing Workflow for Neuroimmunological Investigations Using Neural Networks.
    Lazarczyk M; Duda K; Mickael ME; Ak O; Paszkiewicz J; Kowalczyk A; Horbańczuk JO; Sacharczuk M
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
    Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
    BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
    Chopra G; Samudrala R
    Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PREDOSE: a semantic web platform for drug abuse epidemiology using social media.
    Cameron D; Smith GA; Daniulaityte R; Sheth AP; Dave D; Chen L; Anand G; Carlson R; Watkins KZ; Falck R
    J Biomed Inform; 2013 Dec; 46(6):985-97. PubMed ID: 23892295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repurposing from the perspective of pharmaceutical companies.
    Cha Y; Erez T; Reynolds IJ; Kumar D; Ross J; Koytiger G; Kusko R; Zeskind B; Risso S; Kagan E; Papapetropoulos S; Grossman I; Laifenfeld D
    Br J Pharmacol; 2018 Jan; 175(2):168-180. PubMed ID: 28369768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repurposing by integrated literature mining and drug-gene-disease triangulation.
    Sun P; Guo J; Winnenburg R; Baumbach J
    Drug Discov Today; 2017 Apr; 22(4):615-619. PubMed ID: 27780789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.